Dahong Li

5.4k total citations
181 papers, 4.4k citations indexed

About

Dahong Li is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Dahong Li has authored 181 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Molecular Biology, 45 papers in Pharmacology and 41 papers in Pharmacology. Recurrent topics in Dahong Li's work include Bioactive Natural Diterpenoids Research (36 papers), Biological Activity of Diterpenoids and Biflavonoids (31 papers) and Plant-based Medicinal Research (27 papers). Dahong Li is often cited by papers focused on Bioactive Natural Diterpenoids Research (36 papers), Biological Activity of Diterpenoids and Biflavonoids (31 papers) and Plant-based Medicinal Research (27 papers). Dahong Li collaborates with scholars based in China, United States and Japan. Dahong Li's co-authors include Huiming Hua, Jerzy J. Ganczarczyk, Zhan‐Lin Li, Jinyi Xu, Shengtao Xu, Fanxing Xu, Jiao Bai, Xu Hu, Haonan Li and Kai‐Bo Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Applied Physics and Water Research.

In The Last Decade

Dahong Li

173 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dahong Li China 38 2.2k 913 661 586 577 181 4.4k
Yaping Liu China 43 2.4k 1.1× 1.2k 1.3× 995 1.5× 2.0k 3.4× 1.1k 1.9× 311 7.1k
Guolin Zhang China 34 1.8k 0.8× 875 1.0× 793 1.2× 560 1.0× 847 1.5× 195 3.9k
Fung‐Jou Lu Taiwan 42 1.9k 0.9× 452 0.5× 758 1.1× 636 1.1× 776 1.3× 135 5.2k
Hernán Speisky Chile 42 1.4k 0.7× 646 0.7× 242 0.4× 548 0.9× 884 1.5× 130 5.4k
Michal Holčapek Czechia 48 3.1k 1.4× 1.2k 1.3× 203 0.3× 246 0.4× 222 0.4× 160 6.5k
Abha Sharma India 31 1.7k 0.8× 408 0.4× 274 0.4× 99 0.2× 657 1.1× 129 4.4k
Umar Farooq Pakistan 30 1.0k 0.5× 925 1.0× 384 0.6× 246 0.4× 735 1.3× 205 3.4k
Lingling Yang China 40 2.1k 0.9× 498 0.5× 435 0.7× 291 0.5× 777 1.3× 208 5.3k
Robert J. Turesky United States 51 3.3k 1.5× 1.0k 1.1× 403 0.6× 1.4k 2.4× 876 1.5× 194 8.6k

Countries citing papers authored by Dahong Li

Since Specialization
Citations

This map shows the geographic impact of Dahong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dahong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dahong Li more than expected).

Fields of papers citing papers by Dahong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dahong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dahong Li. The network helps show where Dahong Li may publish in the future.

Co-authorship network of co-authors of Dahong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dahong Li. A scholar is included among the top collaborators of Dahong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dahong Li. Dahong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Mingyu, Fang Gao, K. M. Yu, et al.. (2025). Asiatic acid and its derivatives: Pharmacological insights and applications. European Journal of Medicinal Chemistry. 289. 117429–117429. 2 indexed citations
3.
Cui, Can, Ji Wang, Xiaoyan Huang, et al.. (2024). BACE1 inhibitors from the fruits of Alpinia oxyphylla have efficacy to treat T2DM-related cognitive disorder. Fitoterapia. 178. 106157–106157. 3 indexed citations
4.
Li, Haonan, Chao Wang, Siyuan Wang, et al.. (2024). Design and synthesis of 6,20-epoxy A-ring modified oridonin derivatives with antitumor activity through extrinsic and mitochondrial pathways. Bioorganic Chemistry. 151. 107632–107632. 2 indexed citations
5.
Xue, Chunmei, et al.. (2024). New aporphine alkaloids with antitumor activities from the roots of Thalictrum omeiense. Journal of Asian Natural Products Research. 27(12). 1777–1785. 1 indexed citations
6.
Peng, Xiaohui, Sha Chen, Xiaofan Liu, et al.. (2024). Identification and bioactivity evaluation of twelve previously undescribed depsidone derivatives from Garcinia oligantha. Phytochemistry. 227. 114227–114227.
7.
Li, Dahong, et al.. (2024). Chromones and biflavonoids from Garcinia pedunculata and Garcinia nujiangensis and their anti-inflammatory activity. Phytochemistry. 224. 114166–114166. 7 indexed citations
8.
Peng, Xiaohui, et al.. (2023). Triterpene Derivatives from Garcinia oligantha and Their Anti-Cancer Activity. Plants. 12(1). 192–192. 6 indexed citations
9.
Wang, Chao, Siyuan Wang, Haonan Li, et al.. (2023). Marine-Derived Lead Fascaplysin: Pharmacological Activity, Total Synthesis, and Structural Modification. Marine Drugs. 21(4). 226–226. 13 indexed citations
10.
Wang, Mingying, Yanbing Wang, Siyuan Wang, et al.. (2023). 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione derivatives of brefeldin A: Design, synthesis and cytotoxicity in MDA-MB-231 human breast cancer cells. Bioorganic & Medicinal Chemistry. 90. 117380–117380. 2 indexed citations
11.
Gao, Xiang, et al.. (2023). Discovery of sinomenine/8-Bis(benzylthio)octanoic acid hybrids as potential anti-leukemia drug candidate via mitochondrial pathway. Bioorganic & Medicinal Chemistry Letters. 97. 129545–129545.
12.
Zhu, Huajian, Yang Liu, Dahong Li, et al.. (2022). Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects. Journal of Medicinal Chemistry. 65(16). 11187–11213. 22 indexed citations
13.
Xing, Gang, Dahong Li, Anthony Yiu‐Ho Woo, et al.. (2022). Discovery of a Highly Selective β2-Adrenoceptor Agonist with a 2-Amino-2-phenylethanol Scaffold as an Oral Antiasthmatic Agent. Journal of Medicinal Chemistry. 65(7). 5514–5527. 3 indexed citations
14.
Xu, Shengtao, Hong Yao, Dahong Li, et al.. (2021). Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 64(23). 17346–17365. 27 indexed citations
15.
Li, Haonan, Junjie Yan, Chao Zheng, et al.. (2020). Small-molecule fluorescent probes for H2S detection: Advances and perspectives. TrAC Trends in Analytical Chemistry. 134. 116117–116117. 114 indexed citations
16.
Yao, Hong, Shaowen Xie, Xiaoqian Ma, et al.. (2020). Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 63(15). 8157–8178. 37 indexed citations
17.
Cui, Mengyuan, Haonan Li, Dawei Deng, et al.. (2020). A FRET-based upconversion nanoprobe assembled with an electrochromic chromophore for sensitive detection of hydrogen sulfide in vitro and in vivo. Nanoscale. 12(33). 17517–17529. 16 indexed citations
18.
Hu, Xu, Xiang Gao, Shengtao Xu, et al.. (2019). Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia. Mini-Reviews in Medicinal Chemistry. 20(6). 483–497. 18 indexed citations
19.
Xu, Shengtao, Hong Yao, Mei Hu, et al.. (2017). 6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents. Journal of Natural Products. 80(9). 2391–2398. 29 indexed citations
20.
Xu, Shengtao, Hong Yao, Shanshan Luo, et al.. (2017). A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway. Journal of Medicinal Chemistry. 60(4). 1449–1468. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026